BioNxt Solutions Inc. (CSE:BNXT)

Canada flag Canada · Delayed Price · Currency is CAD
0.4750
+0.0150 (3.26%)
Apr 24, 2025, 10:51 AM EDT
31.94%
Market Cap 53.09M
Revenue (ttm) 42.01K
Net Income (ttm) -6.48M
Shares Out 115.41M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 63,600
Average Volume 65,184
Open 0.4600
Previous Close 0.4600
Day's Range 0.4600 - 0.4850
52-Week Range 0.1700 - 0.6900
Beta 1.61
RSI 46.39
Earnings Date Apr 22, 2025

About BioNxt Solutions

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was f... [Read more]

Sector Healthcare
Founded 2017
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol BNXT
Full Company Profile

Financial Performance

In 2023, BioNxt Solutions's revenue was 372,247, an increase of 25.15% compared to the previous year's 297,442. Losses were -7.72 million, -37.60% less than in 2022.

Financial Statements

News

There is no news available yet.